Belite Bio
(NASDAQ) BLTE
Belite Bio Financials at a Glance
Market Cap
$6.60B
Revenue (TTM)
$0.00
Net Income (TTM)
$77.61M
EPS (TTM)
$-2.30
P/E Ratio
-71.90
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$170.78
Volume
51,890.577
Open
$168.90
Price
$170.78
Volume
51,890.577
Open
$168.90
Previous Close
$165.23
Daily Range
$166.00 - $173.30
52-Week Range
$56.00 - $200.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$170.78
Volume
51,890.577
Open
$168.90
Previous Close
$165.23
Daily Range
$166.00 - $173.30
52-Week Range
$56.00 - $200.00
BLTE News
BLTE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Belite Bio
Industry
Pharmaceuticals
Sector
Health CareEmployees
41
CEO
Yue Hsin Lin, MD, PhD
Website
www.belitebio.comHeadquarters
San Diego, CA 92121, US
BLTE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-17%
Return on Capital
-11%
Return on Assets
-10%
Earnings Yield
-1.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.60B
Shares Outstanding
39.97M
Volume
51.89K
Short Interest
0.00%
Avg. Volume
188.73K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$84.21M
EBITDA
$84.21M
Operating Cash Flow
$36.99M
Capital Expenditure
$178.00K
Free Cash Flow
$37.17M
Cash & ST Invst.
$492.42M
Total Debt
$429.00K
Belite Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$6.60B
N/A
Market Cap/Employee
$264.14M
N/A
Employees
25
N/A
Net Income
$25.32M
-150.7%
EBITDA
$30.77M
-305.9%
Quarterly Fundamentals
Net Cash
$491.99M
+240.2%
Accounts Receivable
$718.00K
+20.9%
Inventory
$0.00
N/A
Long Term Debt
$188.00K
-28.0%
Short Term Debt
$241.00K
-12.7%
Return on Assets
-9.94%
N/A
Return on Invested Capital
-10.93%
N/A
Free Cash Flow
$10.56M
N/A
Operating Cash Flow
$10.38M
N/A